In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma's Strategic Divide: Focus or Diversify

Executive Summary

It looks like the biggest strategic gulf in the industry: focus or diversify? If the CEO thinks he can't rely on R&D to grow his way out of the industry's revenue hole, get ready to live alongside generics and OTC businesses--though he'll downplay to investors the risks of managing different businesses by stressing the commonalities with the core branded efforts and probably won't move into wholly non-pharma businesses. If he's still committed to R&D--get ready for diversification of other sorts, and some pretty clever financial tactics.

Related Content

Lilly To Cease Development Of Alzheimer's Drug
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2009
Pharma R&D: Doing the Same Thing That Didn't Work Before
Best of the Blog: IN VIVO February 2009
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2008
GSK Tries to Mimic Real-World Biotech
Pfizer/Wyeth: Industrializing Pharma?
Biopharma in 2008: What a Difference an Economic Crisis Makes
Lilly and Merck Lead the Way With Asian FIPNet Strategies
Novartis' New Kind of Pharma Deal


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts